Track the 뉴로핏 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 뉴로핏 has recorded 2 reports. Market capitalisation: €89bn. The latest transaction was reported on 30 April 2026 (Purchase). Among the most active insiders: 김창일. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Neurofit is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance patient health.